SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q1 EPS of ($0.21), $0.04 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $15.8 million versus the consensus estimate of $15.7 million.

GUIDANCE:

SOPHiA GENETICS SA sees FY2024 revenue of $78-81 million, versus the consensus of $79.17 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.